Scientist I, Immunology
GenEdit(1 month ago)
About this role
This Scientist I role on GenEdit’s Immunology team focuses on advancing genetic medicines for immune-based diseases using the company’s hydrophilic nanoparticle (HNP) delivery technology. The scientist will help shape and execute R&D strategy for immune programs, contributing to program design and candidate selection for tissue- and cell-specific nucleic acid delivery. The position operates in a highly collaborative, interdisciplinary biotech environment spanning chemistry, formulation, screening, and preclinical groups. The role is based in South San Francisco/Brisbane, CA, within a rapidly growing gene therapy-focused company.
Required Skills
- In Vitro Studies
- In Vivo Studies
- Study Design
- Method Development
- Data Analysis
- Technical Problem Solving
- Scientific Leadership
- Project Planning
- Resource Management
- Staff Mentorship
+18 more
Qualifications
- PhD in Immunology
- PhD in Life Science
About GenEdit
genedit.comGenEdit is a biotechnology company focused on developing innovative therapies by enabling targeted delivery of genetic medicines. The company builds delivery platforms and technologies designed to improve the precision, efficiency, and safety of gene- and nucleic-acid-based treatments across tissues and cell types. GenEdit advances programs toward clinical translation and collaborates with biopharma and research partners to apply its delivery solutions across therapeutic areas and bring new genetic medicines to patients.
Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at GenEdit
Similar Jobs
Senior Research Associate, Pharmacology
Flagship Pioneering, Inc.(29 days ago)
Scientist
Arcellx(8 days ago)
Scientist, LNP Formulations
Flagship Pioneering, Inc.(1 month ago)
Sr Associate Scientist I or II, GPCR Biology
Iambic Therapeutics(3 months ago)
Scientist/Senior Scientist, Wet Lab
Retro(8 days ago)
Senior Scientist, Immunology
Recursion(19 days ago)